Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin.

Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin. Abstract Text:

    yu yunYu Yun,peng chenPeng Chen,chun lan zhengChun Lan Zheng,yong yangYong Yang,wei gang duanWei Gang Duan,lei wangLei Wang,bo heBo He,jia qing maJia Qing Ma,dian hua wangDian Hua Wang,zhi qiang shenZhi Qiang Shen,yu yunYu Yun,peng chenPeng Chen,chun lan zhengChun Lan Zheng,yong yangYong Yang,wei gang duanWei Gang Duan,lei wangLei Wang,bo heBo He,jia qing maJia Qing Ma,dian hua wangDian Hua Wang,zhi qiang shenZhi Qiang Shen,

    The antiinflammatory effects of the copper-aspirin complex (Cu-Asp) were more potent than that of Asp in rats or mice with fewer classic adverse effects. The aim of this study was to determine the cause by evaluating Cu-Asp selective inhibition on cyclooxygenases (COX). COX-1 inhibition was evaluated based on 6-keto-prostaglandin F(1alpha) (6-keto-PGF(1alpha)) in an endothelial cell model, and COX-2 inhibition was based on prostaglandin E(2) (PGE(2)) in a macrophage model. Radioimmunoassay (RIA) was applied to determine 6-keto-PGF(1alpha) in resting human umbilical vein endothelial cell line (ECV304), and PGE(2) in activated macrophages. The results showed that the inhibition of 6-keto-PGF(1alpha) yield by Cu-Asp (3 to 0.01 mM) was markedly weaker than that by aspirin (Asp); while the inhibition of PGE(2) yield by Cu-Asp (10 to 0.1 mM) was significantly stronger than that by Asp. Based on the inhibition on 6-keto-PGF(1alpha) and PGE(2), the medium inhibitory concentration (IC(50)) of Cu-Asp on COX-1 and on COX-2 was 1.03+/-0.15 mM, and 0.32+/-0.04 mM, respectively. The selective inhibition index on COX-2, IC(50) (COX-1)/IC(50) (COX-2), of Cu-Asp was 3.33+/-0.89, while that of Asp was 0.42+/-0.12. The results suggest that, unlike Asp, Cu-Asp is a relatively selective inhibitor of COX-2 in the present models; the selectivity of Cu-Asp is about seven-fold greater than that of Asp.

    Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin. Publishing Authors By Initials

    y yunY Yun,p chenP Chen,cl zhengCL Zheng,y yangY Yang,wg duanWG Duan,l wangL Wang,b heB He,jq maJQ Ma,dh wangDH Wang,zq shenZQ Shen,y yunY Yun,p chenP Chen,cl zhengCL Zheng,y yangY Yang,wg duanWG Duan,l wangL Wang,b heB He,jq maJQ Ma,dh wangDH Wang,zq shenZQ Shen,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Yakugaku zasshi : Journal of the Pharmaceutical So

    VOLUME: 127

    Page Numbers: 1869-75

    Journal Abbreviation: Yakugaku Zasshi

    ISSN: 0031-6903

    DAY: 5

    MONTH: Nov

    YEAR: 2007

    Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 413613

    Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin.

    AFFILIATION: Yunnan Pharmacological Laboratories of Natural Products, Kunming Medical College, Western People's Road, Kunming, PR China.

    Country: Japan

    Japan Research PublicationJapan Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Yakugaku Zasshi

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News